Orchestra BioMed
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $88 | $110 | $30,917 | $861 |
Gross Profit | 63 | 18 | 30,866 | 812 |
EBITDA | -23,659 | -19,780 | 7,090 | -20,747 |
EBIT | -23,755 | -19,870 | 7,008 | -20,828 |
Net Income | -23,755 | -20,691 | 6,245 | -20,828 |
Net Change In Cash | 88 | 110 | 30,917 | 861 |
Free Cash Flow | -19,586 | -22,352 | -2,303 | -14,860 |
Cash | 20,472 | 28,367 | 34,690 | 42,012 |
Basic Shares | 63,812 | 62,721 | 49,966 | 52,186 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $33,482 | $2,638 | $2,760 | $3,533 |
Gross Profit | 33,292 | 2,434 | 2,574 | 3,211 |
EBITDA | -51,226 | -60,716 | -48,833 | -33,386 |
EBIT | -51,553 | -61,024 | -49,120 | -33,608 |
Net Income | -52,701 | -61,024 | -49,120 | -33,608 |
Net Change In Cash | 33,482 | 2,638 | 2,760 | 3,533 |
Free Cash Flow | -49,452 | -50,847 | -46,205 | -29,880 |
Cash | 34,690 | 22,261 | 30,559 | 19,784 |
Basic Shares | 47,747 | 36,821 | 33,225 | 25,472 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.38 |
2026-03-31 | -$0.32 |
2025-12-31 | $0.26 |
2025-09-30 | -$0.40 |